Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
18 mars 2024 07h05 HE
|
Sequel Med Tech
Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
14 mars 2024 16h39 HE
|
CytoSorbents
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market
14 mars 2024 08h15 HE
|
Autonomix Medical, Inc.
First trial to ever evaluate radiofrequency (RF) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer THE WOODLANDS, TX, March 14, 2024 (GLOBE NEWSWIRE) --...
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
13 mars 2024 16h05 HE
|
electroCore, Inc.
Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022 Company to host conference call and webcast today, March 13, 2024 at 4:30pm EST ROCKAWAY,...
electroCore to Participate in Upcoming Investor Conferences
12 mars 2024 08h00 HE
|
electroCore, Inc.
ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Strategy...
Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network
07 mars 2024 08h22 HE
|
Neuronetics
MALVERN, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Noah Medical Named a “Fierce 15” Company of 2023 by Fierce MedTech
06 mars 2024 08h00 HE
|
Noah Medical
Medical robotics innovator Noah Medical announced today that Fierce MedTech has named it one of 2023’s “Fierce 15” medical technology companies.
CytoSorbents to Report Fiscal 2023 Operating and Financial Results
06 mars 2024 07h00 HE
|
CytoSorbents
PRINCETON, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
27 févr. 2024 09h00 HE
|
Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...
Draper vill förbättra ECMO-behandling med CHS™-coatad produkt
27 févr. 2024 04h03 HE
|
Corline Biomedical AB
Draper (The Charles Stark Draper Laboratory Inc.) meddelar att man ingått i partnerskap med US Department of Health and Human Services för att utveckla en innovativ produkt för behandling av akut...